- Home
- GLXG vs CSCI Comparison
GLXG vs CSCI Comparison
Compare GLXG & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLXG
- CSCI
- Stock Information
- Founded
- GLXG 2013
- CSCI 1990
- Country
- GLXG Hong Kong
- CSCI Canada
- Employees
- GLXG N/A
- CSCI N/A
- Industry
- GLXG
- CSCI
- Sector
- GLXG
- CSCI
- Exchange
- GLXG NYSE
- CSCI NYSE
- Market Cap
- GLXG 8.8M
- CSCI 10.6M
- IPO Year
- GLXG 2024
- CSCI 1996
- Fundamental
- Price
- GLXG $0.62
- CSCI $4.30
- Analyst Decision
- GLXG
- CSCI
- Analyst Count
- GLXG 0
- CSCI 0
- Target Price
- GLXG N/A
- CSCI N/A
- AVG Volume (30 Days)
- GLXG 132.9K
- CSCI 4.4K
- Earning Date
- GLXG 08-16-2025
- CSCI 08-12-2025
- Dividend Yield
- GLXG N/A
- CSCI N/A
- EPS Growth
- GLXG N/A
- CSCI N/A
- EPS
- GLXG N/A
- CSCI N/A
- Revenue
- GLXG $3,711,233.00
- CSCI $9,030,000.00
- Revenue This Year
- GLXG N/A
- CSCI N/A
- Revenue Next Year
- GLXG N/A
- CSCI N/A
- P/E Ratio
- GLXG N/A
- CSCI N/A
- Revenue Growth
- GLXG N/A
- CSCI 36.51
- 52 Week Low
- GLXG $0.39
- CSCI $1.96
- 52 Week High
- GLXG $16.93
- CSCI $6.77
- Technical
- Relative Strength Index (RSI)
- GLXG N/A
- CSCI N/A
- Support Level
- GLXG N/A
- CSCI N/A
- Resistance Level
- GLXG N/A
- CSCI N/A
- Average True Range (ATR)
- GLXG 0.00
- CSCI 0.00
- MACD
- GLXG 0.00
- CSCI 0.00
- Stochastic Oscillator
- GLXG 0.00
- CSCI 0.00
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.